secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001493152-23-026879
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity receives Nasdaq deficiency letter for MVLS below $35M minimum
------------------------------------------------------------------------

- On Aug 1, 2023, Biotricity received Nasdaq notice: MVLS < $35M for 30 consecutive business days.
- No immediate delisting effect; company has 180 days (until Jan 29, 2024) to regain compliance.
- To regain compliance, MVLS must close at ≥ $35M for a minimum of 10 consecutive business days.
- Company intends to monitor market value and may consider available options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315223026879/0001493152-23-026879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315223026879/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-026879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer